• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征:轻度认知障碍患者脑淀粉样蛋白的分布情况

Down syndrome: Distribution of brain amyloid in mild cognitive impairment.

作者信息

Keator David B, Phelan Michael J, Taylor Lisa, Doran Eric, Krinsky-McHale Sharon, Price Julie, Ballard Erin E, Kreisl William C, Hom Christy, Nguyen Dana, Pulsifer Margaret, Lai Florence, Rosas Diana H, Brickman Adam M, Schupf Nicole, Yassa Michael A, Silverman Wayne, Lott Ira T

机构信息

Department of Psychiatry and Human Behavior University of California Irvine California.

Institute for Memory Impairments and Neurological Disorders, UC Irvine California.

出版信息

Alzheimers Dement (Amst). 2020 Apr 17;12(1):e12013. doi: 10.1002/dad2.12013. eCollection 2020.

DOI:10.1002/dad2.12013
PMID:32435685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7233421/
Abstract

INTRODUCTION

Down syndrome (DS) is associated with a higher risk of dementia. We hypothesize that amyloid beta (Aβ) in specific brain regions differentiates mild cognitive impairment in DS (MCI-DS) and test these hypotheses using cross-sectional and longitudinal data.

METHODS

18F-AV-45 (florbetapir) positron emission tomography (PET) data were collected to analyze amyloid burden in 58 participants clinically classified as cognitively stable (CS) or MCI-DS and 12 longitudinal CS participants.

RESULTS

The study confirmed our hypotheses of increased amyloid in inferior parietal, lateral occipital, and superior frontal regions as the main effects differentiating MCI-DS from the CS groups. The largest annualized amyloid increases in longitudinal CS data were in the rostral middle frontal, superior frontal, superior/middle temporal, and posterior cingulate cortices.

DISCUSSION

This study helps us to understand amyloid in the MCI-DS transitional state between cognitively stable aging and frank dementia in DS. The spatial distribution of Aβ may be a reliable indicator of MCI-DS in DS.

摘要

引言

唐氏综合征(DS)与患痴呆症的风险较高相关。我们假设特定脑区的β淀粉样蛋白(Aβ)可区分唐氏综合征中的轻度认知障碍(MCI-DS),并使用横断面和纵向数据来检验这些假设。

方法

收集18F-AV-45(氟代贝他吡)正电子发射断层扫描(PET)数据,以分析58名临床分类为认知稳定(CS)或MCI-DS的参与者以及12名纵向CS参与者的淀粉样蛋白负荷。

结果

该研究证实了我们的假设,即顶下叶、枕外侧叶和额上叶区域的淀粉样蛋白增加是区分MCI-DS组和CS组的主要因素。纵向CS数据中年化淀粉样蛋白增加最大的区域是额中回前部、额上叶、颞上/中叶和后扣带回皮质。

讨论

本研究有助于我们了解MCI-DS在唐氏综合征中从认知稳定衰老到明显痴呆的过渡状态下的淀粉样蛋白情况。Aβ的空间分布可能是唐氏综合征中MCI-DS的可靠指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc8/7233421/6a9e6e0f9e26/DAD2-12-e12013-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc8/7233421/d65c4f59c488/DAD2-12-e12013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc8/7233421/fd60d2b349eb/DAD2-12-e12013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc8/7233421/6a9e6e0f9e26/DAD2-12-e12013-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc8/7233421/d65c4f59c488/DAD2-12-e12013-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc8/7233421/fd60d2b349eb/DAD2-12-e12013-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fc8/7233421/6a9e6e0f9e26/DAD2-12-e12013-g003.jpg

相似文献

1
Down syndrome: Distribution of brain amyloid in mild cognitive impairment.唐氏综合征:轻度认知障碍患者脑淀粉样蛋白的分布情况
Alzheimers Dement (Amst). 2020 Apr 17;12(1):e12013. doi: 10.1002/dad2.12013. eCollection 2020.
2
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
3
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study.淀粉样蛋白 PET 和 tau-PET 评估唐氏综合征患者症状性阿尔茨海默病的时间轴:一项纵向队列研究。
Lancet Neurol. 2024 Dec;23(12):1214-1224. doi: 10.1016/S1474-4422(24)00426-5.
4
Elevated CSF GAP-43 in Mild Cognitive Impairment Linked to Cognitive Impairment Through Increased Amyloid-β Accumulation, with a Shift to Reduced Amyloid-β Accumulation in Alzheimer's Disease.轻度认知障碍患者脑脊液中生长相关蛋白43(GAP-43)升高,通过淀粉样β蛋白(Aβ)积累增加与认知障碍相关,而在阿尔茨海默病中则转变为Aβ积累减少。
J Mol Neurosci. 2025 Mar 20;75(2):39. doi: 10.1007/s12031-025-02333-8.
5
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者淀粉样蛋白负担的比较:一项横断面研究。
Lancet Neurol. 2023 Jan;22(1):55-65. doi: 10.1016/S1474-4422(22)00408-2.
6
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
7
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
8
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
9
Joint spatial associations of amyloid beta and tau pathology in Down syndrome and preclinical Alzheimer's disease: Cross-sectional associations with early cognitive impairments.唐氏综合征和临床前阿尔茨海默病中β-淀粉样蛋白和tau病理的联合空间关联:与早期认知障碍的横断面关联
Alzheimers Dement. 2025 Jul;21(7):e70424. doi: 10.1002/alz.70424.
10
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study.利用血浆生物标志物预测唐氏综合征患者的淀粉样蛋白和tau蛋白脑沉积及认知衰退:一项纵向队列研究。
Lancet Neurol. 2025 Jul;24(7):591-600. doi: 10.1016/S1474-4422(25)00158-9.

引用本文的文献

1
The striatum is an early, accurate indicator of amyloid burden using [C]PiB in Down syndrome: Comparison of two radiotracers.在唐氏综合征中,纹状体是使用[C]PiB检测淀粉样蛋白负荷的早期、准确指标:两种放射性示踪剂的比较。
Alzheimers Dement. 2025 Apr;21(4):e70141. doi: 10.1002/alz.70141.
2
A neuropathology case report of a woman with Down syndrome who remained cognitively stable: Implications for resilience to neuropathology.一名患有唐氏综合征且认知保持稳定的女性的神经病理学病例报告:对神经病理学恢复力的启示
Alzheimers Dement. 2025 Feb;21(2):e14479. doi: 10.1002/alz.14479. Epub 2025 Jan 27.
3
The striatum is an early, accurate indicator of amyloid burden using [C]PiB in Down syndrome: comparison of two radiotracers.

本文引用的文献

1
Caregiving, intellectual disability, and dementia: Report of the Summit Workgroup on Caregiving and Intellectual and Developmental Disabilities.照护、智力残疾与痴呆症:照护及智力与发育障碍问题峰会工作组报告
Alzheimers Dement (N Y). 2018 Jul 10;4:272-282. doi: 10.1016/j.trci.2018.06.002. eCollection 2018.
2
Prevalence of Aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome.老年痴呆症和多种共病在唐氏综合征老年患者中的流行情况。
JAMA Neurol. 2018 Nov 1;75(11):1399-1406. doi: 10.1001/jamaneurol.2018.2210.
3
Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.
纹状体是唐氏综合征中使用[C]匹兹堡化合物B(PiB)检测淀粉样蛋白负荷的早期准确指标:两种放射性示踪剂的比较。
medRxiv. 2024 Dec 6:2024.12.04.24318526. doi: 10.1101/2024.12.04.24318526.
4
Association of plasma neurofilament light chain with microstructural white matter changes in Down syndrome.唐氏综合征患者血浆神经丝轻链与脑白质微结构改变的关联
Alzheimers Dement (Amst). 2024 Nov 22;16(4):e70023. doi: 10.1002/dad2.70023. eCollection 2024 Oct-Dec.
5
Abnormal degree centrality and functional connectivity in Down syndrome: A resting-state fMRI study.唐氏综合征患者的异常度中心性和功能连接性:一项静息态功能磁共振成像研究。
Int J Clin Health Psychol. 2023 Jan-Apr;23(1):100341. doi: 10.1016/j.ijchp.2022.100341. Epub 2022 Oct 6.
6
Exploring the role of sex differences in Alzheimer's disease pathogenesis in Down syndrome.探索性别差异在唐氏综合征阿尔茨海默病发病机制中的作用。
Front Neurosci. 2022 Aug 12;16:954999. doi: 10.3389/fnins.2022.954999. eCollection 2022.
7
Joint-label fusion brain atlases for dementia research in Down syndrome.用于唐氏综合征痴呆症研究的联合标签融合脑图谱。
Alzheimers Dement (Amst). 2022 May 25;14(1):e12324. doi: 10.1002/dad2.12324. eCollection 2022.
8
Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.选择性损害长程默认模式网络功能连接作为唐氏综合征患者临床前阿尔茨海默病的生物标志物。
J Alzheimers Dis. 2022;85(1):153-165. doi: 10.3233/JAD-210572.
9
Establishing diagnostic thresholds for Alzheimer's disease in adults with Down syndrome: the Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and Others with Intellectual Disabilities (CAMDEX-DS).确定唐氏综合征成年人患阿尔茨海默病的诊断阈值:剑桥唐氏综合征及其他智障老年人精神障碍检查(CAMDEX-DS)。
BJPsych Open. 2021 Apr 13;7(3):e79. doi: 10.1192/bjo.2021.36.
10
Multi-Modal Imaging in Down's Syndrome: Maximizing Utility Through Innovative Neuroimaging Approaches.唐氏综合征的多模态成像:通过创新神经成像方法实现效用最大化
Front Neurol. 2021 Jan 7;11:629463. doi: 10.3389/fneur.2020.629463. eCollection 2020.
早期纹状体淀粉样蛋白沉积可将唐氏综合征和常染色体显性阿尔茨海默病与晚发性淀粉样蛋白沉积区分开来。
Alzheimers Dement. 2018 Jun;14(6):743-750. doi: 10.1016/j.jalz.2018.01.002. Epub 2018 Mar 1.
4
Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals.结构束改变可预测淀粉样蛋白阳性老年个体下游tau蛋白的积累。
Nat Neurosci. 2018 Mar;21(3):424-431. doi: 10.1038/s41593-018-0070-z. Epub 2018 Feb 5.
5
Why do so many clinical trials of therapies for Alzheimer's disease fail?为什么这么多治疗阿尔茨海默病的疗法临床试验会失败?
Lancet. 2017 Nov 25;390(10110):2327-2329. doi: 10.1016/S0140-6736(17)32399-1.
6
Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome.唐氏综合征成年人3年内的认知衰退与脑淀粉样β蛋白积累
Neurobiol Aging. 2017 Oct;58:68-76. doi: 10.1016/j.neurobiolaging.2017.05.019. Epub 2017 Jun 2.
7
Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population.非痴呆唐氏综合征人群中淀粉样蛋白正电子发射断层扫描和容积磁共振成像的纵向变化。
Alzheimers Dement (Amst). 2017 May 23;9:1-9. doi: 10.1016/j.dadm.2017.05.001. eCollection 2017.
8
Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.唐氏综合征、21号染色体部分三体与阿尔茨海默病的缺失:淀粉样前体蛋白(APP)的作用
J Alzheimers Dis. 2017;56(2):459-470. doi: 10.3233/JAD-160836.
9
Defining imaging biomarker cut points for brain aging and Alzheimer's disease.定义脑老化和阿尔茨海默病的影像学生物标志物切点。
Alzheimers Dement. 2017 Mar;13(3):205-216. doi: 10.1016/j.jalz.2016.08.005. Epub 2016 Sep 30.
10
Different partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of aging.不同的部分容积校正方法会得出不同的结论:一项关于衰老的(18)F-FDG-PET研究。
Neuroimage. 2016 May 15;132:334-343. doi: 10.1016/j.neuroimage.2016.02.042. Epub 2016 Feb 23.